Cytokinetics
CYTK
#1974
Rank
NZ$18.10 B
Marketcap
NZ$133.36
Share price
3.18%
Change (1 day)
137.63%
Change (1 year)

EPS for Cytokinetics (CYTK)

EPS in 2026 (TTM): NZ-$11.73

According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is NZ-$11.75. In 2025 the company made an earnings per share (EPS) of NZ-$11.22 a decrease over its 2024 EPS that were of NZ-$9.04.

EPS history for Cytokinetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$11.734.52%
2025NZ-$11.2224.14%
2024NZ-$9.04-3.49%
2023NZ-$9.3728.24%
2022NZ-$7.3050.18%
2021NZ-$4.8640.8%
2020NZ-$3.45
2018NZ-$3.35-24.12%
2017NZ-$4.42-776.32%
2016NZ$0.65-139.18%
2015NZ-$1.67125.58%
2014NZ-$0.74-67.67%
2013NZ-$2.29-44.58%
2012NZ-$4.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
NZ$24.88-311.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
NZ-$59.70 407.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$10.83-192.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ-$86.46 635.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
NZ-$1.25-89.33%๐Ÿ‡บ๐Ÿ‡ธ USA